Results 221 to 230 of about 45,024 (296)

Management of Bleeding Disorder During Dual Antiplatelet Therapy. [PDF]

JACC Case Rep
Madaudo C, Galassi AR, Vadalà G.
europepmc   +1 more source

Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early‐Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized‐Controlled Trials

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Early‐phase clinical trials focus heavily on demonstrating safety and tolerability of drug candidates. Clinical laboratory test results outside of reference intervals (RIs) are often interpreted as possible indicators of harm. However, values outside RIs do not necessarily constitute drug‐induced adverse effects.
Jannik Rousel, Tessa Niemeyer‐van der Kolk, Matthijs Moerland, Robert Rissmann, Naomi B. Klarenbeek, Maurits F. J. M. Vissers, Jacobus Burggraaf   +6 more
wiley   +1 more source

Thromboembolic disease and hemostatic alterations in tumor-bearing dogs - A narrative review. [PDF]

Front Vet Sci
Pazzi P, Kristensen AT.
europepmc   +1 more source

Common Hematologic Emergencies—Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias—A Pivotal Role of Clinical Laboratory

International Journal of Laboratory Hematology, Volume 48, Issue 3, Page 521-530, June 2026.
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova, Nicolas Ulrich Edgar, Anton V. Rets   +2 more
wiley   +1 more source

Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Antithrombotic-Treated Cardiac Patients: A Cross-Sectional Study from Sana'a City, Yemen. [PDF]

Vasc Health Risk Manag
Amer AH, Al-Adhroey AH, Al-Shammakh AA.
europepmc   +1 more source

Myeloid Cell Function and Cytokine Profiles in Paediatric Haemophilia A: Insights From FVIII and Emicizumab Prophylaxis

Journal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT Haemophilia A (HA) is an X‐linked bleeding disorder caused by factor VIII (FVIII) deficiency, treated with FVIII infusions or, more recently, Emicizumab subcutaneously. Although Emicizumab is safe and effective, FVIII is still required for severe bleeding, trauma, or surgery, and few studies have compared these prophylactic options in ...
Alessia Cottonaro, Saicharan Akula, Berardino Pollio, Irene Ricca, Tiziano Martini, Roberto Albiani, Jacopo Agnelli Giacchello, Patrizia Sciancalepore, Roberto Santi, Antonia Follenzi, Simone Merlin   +10 more
wiley   +1 more source

Effect of Hyperthermia on Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (APTT). [PDF]

Cureus
Devi J, Kakkar N, Sharma A.
europepmc   +1 more source

Supraumbillical Skin Retraction After Laser Assisted Liposuction/Lipolysis

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Supraumbilical skin laxity is a major surgical challenge. A literature review on laser‐assisted liposuction/lipolysis (LAL/L) speaks in favor of skin tightening. Alternative methods include visible postoperative scar. Aims The aim is to determine the vertical retraction of the supraumbilical skin and its association with age, gender,
Ivonne Žgaljardić, Sanda Smuđ Orehovec, Krešimir Bulić, Filip Jurić, Vilena Vrbanović Mijatović, Mirna Bobinac, Kristina Uglešić, Davor Mijatović   +7 more
wiley   +1 more source

Resolving Bivalirudin Interference on Fibrinogen Testing by the Use of Activated Carbon. [PDF]

J Clin Lab Anal
Du J, Liu H, Liu X, Cao S, Zhang Z, Zhang L.   +5 more
europepmc   +1 more source